Covid-19: Contracts and Public Inquiry

Debate between Dave Doogan and Angela Richardson

Wednesday 7th July 2021 Commons Chamber

[Angela Richardson]

I agree with my right hon. Friend: as always, he makes an excellent point.

We have acted at pace to protect our NHS and save lives, by delivering more than 11 billion items of personal protective equipment to our key workers and helping to protect all those working on the frontline in our fight against the virus. From the onset of the pandemic, we have acted at pace to secure the PPE that we all need. We purchased over 32 billion items for the whole of the UK, three quarters of which will now be provided by British manufacturers—that is massive upscaling at speed—and we have distributed over 11.7 billion items of PPE across England since February 2020.

We have talked about the success of the vaccine roll- out, but what was amazing was securing those 507 million doses of the eight most promising vaccines through our vaccine taskforce for every corner of our Union. We can be incredibly proud not only of that but of the investment in the COVAX project.

[Dave Doogan]

Let me share with the hon. Lady my appreciation that the vaccine roll-out has been a tremendous success. I am not certain that any of my colleagues said that it was not a tremendous success. Does she agree, however, that it is the one thing that this Government got right in the whole pandemic, and that a vaccine never brought anybody back from the dead?

[Angela Richardson]

I thank the hon. Gentleman for his intervention, but I think he is being a little bit too narrow in his focus by saying that we only got one thing right. The way we invested in that scheme was replicated across many areas. We rightly hold that up as the absolute beacon of success, but there are many other areas where we used similar sorts of processes and where we had successes. We need to keep that in mind. Our diagnostic capacity has been excellent at identifying new strains, and we have to discuss that as well.